Golden State Wealth Management LLC Lowers Stock Position in UnitedHealth Group Incorporated $UNH

Golden State Wealth Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 45.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 897 shares of the healthcare conglomerate’s stock after selling 750 shares during the quarter. Golden State Wealth Management LLC’s holdings in UnitedHealth Group were worth $280,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. HHM Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares during the period. Brogan Financial Inc. lifted its position in shares of UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after acquiring an additional 27 shares during the period. West Wealth Group LLC boosted its stake in shares of UnitedHealth Group by 3.2% during the 1st quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock worth $462,000 after acquiring an additional 27 shares in the last quarter. Hemington Wealth Management increased its stake in UnitedHealth Group by 2.5% in the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock valued at $604,000 after purchasing an additional 28 shares in the last quarter. Finally, Tlwm boosted its position in UnitedHealth Group by 1.0% during the first quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock worth $1,433,000 after purchasing an additional 28 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Oppenheimer reduced their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. UBS Group raised their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. JPMorgan Chase & Co. increased their target price on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Finally, Sanford C. Bernstein boosted their price target on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Eighteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $324.29 on Friday. The stock has a fifty day moving average price of $345.84 and a 200 day moving average price of $323.37. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The firm has a market capitalization of $293.75 billion, a P/E ratio of 16.93, a PEG ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the business earned $7.15 EPS. The firm’s revenue was up 12.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.